By

NEWS RELEASE Colorado State University is aiding in the development of vaccines to protect U.S. soldiers from Ebola and Marburg, both deadly diseases caused by filoviruses. BioMARC, a high-containment...

By

The World Health Organization (WHO) welcomes the approval by Swissmedic, the Swiss regulatory authority for therapeutic products, for a trial with an experimental Ebola vaccine at the Lausanne University...

By

Johnson & Johnson today announced that it has made a commitment of up to $200 million to accelerate and significantly expand the production of an Ebola vaccine program in development at its Janssen...

The strain of Neisseria meningitis, the agent of meningococcal disease, that killed 18-year-old  San Diego State University (SDSU) freshman Sara Stelzer is the same strain seen in outbreaks of meningococcal...

By

A study to determine whether vaccines, particularly those for hepatitis B (HepB) and human papillomavirus (HPV), increased the risk of multiple sclerosis (MS) or other acquired central nervous system demyelinating...

By

The Government of Canada will ship 800 vials of its experimental Ebola vaccine to the World Health Organization (WHO) in Geneva, beginning with its first shipment on Monday, October 20, 2014. The vaccine...

By

The development of a vaccine to prevent Ebola virus disease will be accelerated with support from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness...

By

Sanofi Pasteur, the vaccines division of Sanofi, announced today the start of a phase III clinical trial in India for its investigational rotavirus vaccine, developed and manufactured by its affiliate...

By

Canada’s Minister of Health, Rona Ambrose, announced Monday the the launch of Phase 1 clinical trials for Canada’s Ebola vaccine (VSV-EBOV) at the Walter Reed Army Institute of Research in Silver...

By

An experimental vaccine to protect people against H7N9 avian influenza prompted immune responses in 59 percent of volunteers who received two injections at the lowest dosage tested, but only if the vaccine...